Agile Therapeutics Inc
AGRXDelisted Jun 3, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001261249
Agile Therapeutics Inc was delisted on Jun 3, 2024; its insiders filed their last Form 4 on Aug 26, 2024; 21 institutions reported holding it in 13F filings for Q4 2023, worth $496.2K in total; no superinvestor held it.
Holders of 5% or more of AGRX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Agile Therapeutics Inc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Mastrangeli Doug | 13G | 5.10%350.0K shares | New | Aug 26, 20241 filing | Aug 26, 2024 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
4 Schedule 13D and 13G filings on Agile Therapeutics Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 26, 20244:47 PM ET | Mastrangeli Doug | 13G | 5.10%350.0K shares | New | Aug 6, 2024 | SEC |
| Feb 16, 2021 | Perceptive Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Vanguard Group Inc | 13GOld format | – | New | – | SEC |
| Feb 10, 2021 | Renaissance Technologies LLC | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Agile Therapeutics Inc shares.
No Form 144 notices for Agile Therapeutics Inc are on file.